Crinetics Pharmaceuticals, Inc. - COM (CRNX)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / COM
Number of holders
137
Total Shares
54M
Shares change
-1.01M
Total reported value, excl. options
$973M
Value change
-$11.9M
Put/Call ratio
19.18
Number of buys
80
Number of sells
-48
Price
$18.02
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.